Genmab | GEN - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Almirall EUR 71.55M 41.32M 2026-06
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.61B 777M 2026-06
argenx SE USD 493M 99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 827M 2.7B 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Demant DKK 2.09B 224M 2025-12
Exelixis USD 248.41M 2.93M 2026-06
Fresenius Medical Care EUR 537.27M 269.27M 2026-06
Genmab DKK 407M 182M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GN Store Nord DKK -68M 638M 2026-03
GRIFOLS EUR 329M 80M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Lonza CHF 673M 243M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.75B 515M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
UCB EUR 1.29B 571M 2025-12